BEER-SHEVA, Israel...October 6, 2016 - Ben-Gurion University of the Negev (BGU) researchers are a step closer to understanding the genetic basis of autism, which they hope will lead to earlier diagnosis of what is rapidly becoming the most prevalent developmental disorder worldwide.
In the study published in Behavior Genetics, the researchers examined the sequences of more than 650 genes associated with autism and discovered characteristics that distinguish them from other brain-specific genes and genes of other diseases.
According to the U.S. Centers for Disease Control and Prevention (CDC), one in 50 children in the United States is diagnosed with autism, a neurodevelopmental disorder which can severely impair communication and social skills. These figures have skyrocketed since the 1980s, when only one in 5,000 were diagnosed with an autism spectrum disorder (ASD).
"We are now a step closer to understanding the genes associated with autism and understanding the biological process involved in the disease," says Dr. Idan Menashe, who along with his colleagues, Erez Tsur and Prof. Michael Friger, is a member of the BGU Department of Public Health in the Faculty of Health Sciences. Dr. Menashe and Tsur are also members of BGU's Zlotowski Center for Neuroscience.
"This study gives us a tool to help identify additional autism genes using the genetic signature we found. From there, we hope to be able to diagnose autism earlier," the researchers say.
One particularly distinct characteristic of autism genes the researchers found is their exceptional genomic length, which is longer than other brain-expressed genes of closely related diseases such as Alzheimer's and schizophrenia.
Additionally, when the researchers studied families that have a child diagnosed with ASD, they found a unique genomic signature shaped by negative selection, an evolutionary process that purifies and removes disruptive mutations from genes and prevents them from replicating over generations.
Dr. Menashe and his colleagues also searched for evidence of positive selection in these genes, which would cause an increase in frequency until they are a factor in the population. "While this kind of mechanism could explain the prevalence of autism in the human population, we found no indications of positive selection acting on autism genes," he says. "Thus, while autism susceptibility mutations are in the human genome, they only present as an autism disorder when combined with other genetic, non-genetic or environmental factors.
"Our findings suggest that ASD genes have evolved under complex evolutionary forces, which have left a unique signature that can be used to identify new ASD candidate genes," the researchers add.
About American Associates, Ben-Gurion University of the Negev
American Associates, Ben-Gurion University of the Negev (AABGU) plays a vital role in sustaining David Ben-Gurion's vision: creating a world-class institution of education and research in the Israeli desert, nurturing the Negev community and sharing the University's expertise locally and around the globe. As Ben-Gurion University of the Negev (BGU) looks ahead to turning 50 in 2020, AABGU imagines a future that goes beyond the walls of academia. It is a future where BGU invents a new world and inspires a vision for a stronger Israel and its next generation of leaders. Together with supporters, AABGU will help the University foster excellence in teaching, research and outreach to the communities of the Negev for the next 50 years and beyond. Visit vision.aabgu.org to learn more.
AABGU, which is headquartered in Manhattan, has nine regional offices throughout the United States. For more information, visit http://www.aabgu.org.